X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs SHASUN PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD SHASUN PHARMA STRIDES SHASUN LTD/
SHASUN PHARMA
 
P/E (TTM) x 44.2 123.9 35.7% View Chart
P/BV x 1.1 8.5 12.9% View Chart
Dividend Yield % 0.9 0.2 386.7%  

Financials

 STRIDES SHASUN LTD   SHASUN PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
SHASUN PHARMA
Mar-14
STRIDES SHASUN LTD/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,27594 1,353.2%   
Low Rs91846 2,013.2%   
Sales per share (Unadj.) Rs389.6214.2 181.9%  
Earnings per share (Unadj.) Rs28.05.3 524.1%  
Cash flow per share (Unadj.) Rs48.915.8 309.1%  
Dividends per share (Unadj.) Rs4.501.00 450.0%  
Dividend yield (eoy) %0.41.4 28.7%  
Book value per share (Unadj.) Rs303.153.3 568.3%  
Shares outstanding (eoy) m89.4256.62 157.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.80.3 862.3%   
Avg P/E ratio x39.213.1 299.2%  
P/CF ratio (eoy) x22.44.4 507.4%  
Price / Book Value ratio x3.61.3 276.0%  
Dividend payout %16.118.7 85.9%   
Avg Mkt Cap Rs m98,0363,958 2,477.1%   
No. of employees `0005.8NA-   
Total wages/salary Rs m5,8812,164 271.8%   
Avg. sales/employee Rs Th6,005.9NM-  
Avg. wages/employee Rs Th1,014.0NM-  
Avg. net profit/employee Rs Th431.2NM-  
INCOME DATA
Net Sales Rs m34,83412,127 287.2%  
Other income Rs m1,686229 735.0%   
Total revenues Rs m36,52012,356 295.6%   
Gross profit Rs m6,4281,009 637.0%  
Depreciation Rs m1,872594 315.3%   
Interest Rs m2,269415 546.7%   
Profit before tax Rs m3,973230 1,729.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m40 -1,200.0%   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470-73 -646.3%   
Profit after tax Rs m2,501302 827.8%  
Gross profit margin %18.58.3 221.8%  
Effective tax rate %11.8-31.7 -37.4%   
Net profit margin %7.22.5 288.2%  
BALANCE SHEET DATA
Current assets Rs m38,1656,884 554.4%   
Current liabilities Rs m30,4028,456 359.5%   
Net working cap to sales %22.3-13.0 -172.0%  
Current ratio x1.30.8 154.2%  
Inventory Days Days7762 125.5%  
Debtors Days Days104108 97.1%  
Net fixed assets Rs m37,6394,970 757.3%   
Share capital Rs m894113 789.2%   
"Free" reserves Rs m26,2102,875 911.7%   
Net worth Rs m27,1053,020 897.4%   
Long term debt Rs m16,3771,817 901.1%   
Total assets Rs m81,16813,347 608.1%  
Interest coverage x2.81.6 177.1%   
Debt to equity ratio x0.60.6 100.4%  
Sales to assets ratio x0.40.9 47.2%   
Return on assets %5.95.4 109.4%  
Return on equity %9.210.0 92.2%  
Return on capital %12.113.3 90.5%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m13,4655,843 230.5%   
Fx outflow Rs m4,0762,173 187.6%   
Net fx Rs m9,3893,669 255.9%   
CASH FLOW
From Operations Rs m2,881398 724.7%  
From Investments Rs m-7,051-1,635 431.3%  
From Financial Activity Rs m3,3821,309 258.5%  
Net Cashflow Rs m-78871 -1,106.1%  

Share Holding

Indian Promoters % 27.7 39.2 70.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 3.6 1,050.0%  
FIIs % 8.6 17.6 48.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 39.6 65.4%  
Shareholders   56,241 20,750 271.0%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

STRIDES SHASUN LTD Announces Quarterly Results (1QFY19); Net Profit Down 57.5% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, STRIDES SHASUN LTD has posted a net profit of Rs 38 m (down 57.5% YoY). Sales on the other hand came in at Rs 7 bn (down 21.2% YoY). Read on for a complete analysis of STRIDES SHASUN LTD's quarterly results.

STRIDES SHASUN LTD Announces Quarterly Results (4QFY18); Net Profit Down 99.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, STRIDES SHASUN LTD has posted a net profit of Rs 8 m (down 99.2% YoY). Sales on the other hand came in at Rs 7 bn (down 25.2% YoY). Read on for a complete analysis of STRIDES SHASUN LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Sep 18, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS